| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |